THE FEATURES OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH METABOLIC SYNDROME

THE FEATURES OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH METABOLIC SYNDROME

Show other versions (1)

<p>Arterial hypertension (HT) in patients with metabolic syndrome has features (early damage of target organ, a predisposition to thrombosis, refractory to standard antihypertensive therapy, high cardiovascular risk). The aim of HT treatment in patients with metabolic syndrome includes not onl...

Full description

Bibliographic Details
Main Authors:	L. V. Kremneva, O. V. Abaturova, S. V. Shalaev
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	метаболический синдром инсулинорезистентность артериальная гипертензия антигипертензивная терапия многоцентровые исследования
Online Access:	http://www.rpcardio.ru/jour/article/view/26

Similar Items

Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy
by: L. I. Abasova, et al.
Published: (2011-08-01)

Combined antihypertensive therapy in treating patients with metabolic syndrome
by: V. B. Mychka, et al.
Published: (2008-06-01)

Effective antihypertensive therapy: focus on adherence management
by: S. S. Bunova, et al.
Published: (2020-11-01)

Antihypertensive therapy in patients with cerebrovascular pathology: actual aspects and rational approaches
by: Z. A. Suslina, et al.
Published: (2005-06-01)

THE ANALYSIS OF CIRCULATING ENDOTHELIOCYTES IN PERIPHERAL BLOOD AT PATIENTS WITH METABOLIC SYNDROME FROM KHAKASSIA
by: Olga Alexandrovna Berseneva, et al.
Published: (2018-04-01)

STUDY OF PATIENTS ADHERENCE TO TREATMENT IN METABOLIC SYNDROME, WITH THE NOVEL COMBINATION ANTIHYPERTENSION COMPOUND OF RAMIPRIL AND AMLODIPINE BY THE DATA OF OBSERVATIONAL STUDY GRANAT-1
by: S. Yu. Martsevich, et al.
Published: (2017-02-01)

Metabolic syndrome treatment: focusing on acarbose
by: I. E. Chazova, et al.
Published: (2008-04-01)

Algorithm for selection of antihypertensive treatment in patients with metabolic syndrome and hypertension
by: S. V. Nedogoda, et al.
Published: (2013-12-01)

Arterial hypertension in women with climacteric syndrome
by: V. I. Podzolkov, et al.
Published: (2005-10-01)

THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

Prevalence of metabolic syndrome and its components in patients with arterial hypertension and obesity
by: I. E. Chazova, et al.
Published: (2005-12-01)

THE INFLUENCE OF INSULIN RESISTANCE ON THE FORMATION AND PROGRESSION OF METABOLIC SYNDROME COMPONENTS (THE RESULTS OF A FIVE-YEAR STUDY)
by: G. E. Roytberg, et al.
Published: (2015-09-01)

Optimizing antihypertensive therapy in postmenopausal women with metabolic syndrome
by: O. N. Poryvkina, et al.
Published: (2009-06-01)

METABOLIC EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES
by: M. E. Statsenko, et al.
Published: (2015-09-01)

COMPARATIVE EFFECTIVENESS OF FIXED-DOSE COMBINATIONS OF LISINOPRIL/AMLODIPINE AND ENALAPRIL/HYDROCHLOROTHIAZIDE
by: S. V. Nedogoda, et al.
Published: (2013-04-01)

USE OF URAPIDIL - ANTIHYPERTENSIVE DRUG WITH DOUBLE ACTION - NEW DIRECTION IN TREATMENT OF HYPERTENSIVE CRISES
by: V. R. Abdrakhmanov, et al.
Published: (2015-09-01)

Rational antihypertensive therapy in patients with obstructive sleep apnea
by: M. V. Gorbunova, et al.
Published: (2019-03-01)

Hormone replacement therapy effectiveness and safety in postmenopausal women with metabolic syndrome
by: O. N. Poryvkina, et al.
Published: (2009-02-01)

Vliyanie terapii bisoprololom i aktoveginom na perfuziyu golovnogo mozga u patsientov s metabolicheskim sindromom
by: V B Mychka, et al.
Published: (2005-03-01)

Advantages of telmisartan pharmacotherapy in elderly patients with arterial hypertension and metabolic syndrome who have suffered an ischemic stroke
by: O. A. Osipova, et al.
Published: (2022-10-01)

Perindopril metabolic effects and organo-protective action in metabolic syndrome patients
by: V. B. Mychka, et al.
Published: (2007-04-01)

Resistant arterial hypertension: is it really so or have we missed something?
by: V. A. Ionin
Published: (2022-05-01)

Antihypertensive therapy and diabetes mellitus incidence: is it possible to reduce the risk?
by: M. G. Glezer
Published: (2008-12-01)

Moxonidine-based combination antihypertensive therapy in patients with metabolic syndrome
by: E. V. Tishina, et al.
Published: (2012-06-01)

Metabolic syndrome and angiotensin II receptor antagonists
by: K. M. Mamyrbayeva, et al.
Published: (2007-04-01)

Essential arterial hypertension in women, or female arterial hypertension?
by: V. I. Podzolkov, et al.
Published: (2012-02-01)

Vozmozhnosti telmisartana v ANGIO- i KArdioprotektsii i uluchshenii pokazateley uglevodnogo obmena pri narushenii tolerantnosti k glyukoze
by: Sergey Vladimirovich Nedogoda, et al.
Published: (2009-06-01)

Vliyanie terapii bisoprololom na perfuziyu golovnogo mozga u bol'nykh s metabolicheskim sindromom
by: V B Mychka, et al.
Published: (2006-03-01)

Renin-angiotensin-aldosterone system in climacteric women with arterial hypertension. Antihypertensive therapy features
by: A. E. Bragina, et al.
Published: (2005-12-01)

Multiple-factor of metabolic disturbances at women of genesial age in a postovariectomy state
by: L. V. Pokul, et al.
Published: (2009-06-01)

Preimushchestva vklyucheniya v terapiyu bol'nykh s metabolicheskim sindromom i arterial'noy gipertenziey statinov: dopolnitel'nye vozmozhnosti organoprotektsii
by: M E Statsenko, et al.
Published: (2007-06-01)

PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC STUDIES OF ANTIHYPERTENSIVE TREATMENT IN RUSSIA. Analytical Review
by: T. S. Romanenko, et al.
Published: (2015-09-01)

Two strategies for arterial hypertension treatment in patients with secondary chronic pyelonephritis
by: M. E. Statsenko, et al.
Published: (2011-08-01)

Analysis of pregnancy, childbirth, postpartum and fetal development in women with obesity and metabolic syndrome
by: E M Muradyan, et al.
Published: (2012-12-01)

URAPIDIL IN THE TREATMENT OF MEDICAL EMERGENCIES CAUSED BY BLOOD PRESSURE INCREASE
by: N. I. Gaponova, et al.
Published: (2015-12-01)

Primenenie karvedilola u bol'nykh s metabolicheskim sindromom
by: V B Mychka, et al.
Published: (2005-06-01)

Open, multi-center randomized research and clinical program MINOTAUROS: intermediate data analysis
by: I. E. Chazova, et al.
Published: (2006-04-01)

The role of prolactin in the development of hypertension and metabolic syndrome in children
by: N. N. Kaladze, et al.
Published: (2016-07-01)

LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

Early menopause influence on the development of metabolic syndrome
by: L V Kovalenko, et al.
Published: (2011-03-01)